Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients

J Infect. 2022 Aug;85(2):174-211. doi: 10.1016/j.jinf.2022.05.003. Epub 2022 May 9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Immunogenicity, Vaccine
  • Immunologic Deficiency Syndromes*
  • Immunosuppression Therapy
  • Kidney Diseases*
  • SARS-CoV-2
  • Vaccines, Inactivated

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • Vaccines, Inactivated